Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

Alexandra G. Mills; Amy C. Dupper; Kieran I. Chacko; Bremy Alburquerque; Devika Nadkarni; Ana Berbel Caban; Lindsey Fox; Melissa R. Gitman; Ajay Obla; Harm Van Bakel; Deena R. Altman

doi:10.1017/ash.2023.163

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

Alexandra G. Mills
, Amy C. Dupper
, Kieran I. Chacko
, Bremy Alburquerque
, Devika Nadkarni
, Ana Berbel Caban
, Lindsey Fox
, Melissa R. Gitman
, Ajay Obla
, Harm Van Bakel
, Deena R. Altman

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

This case-control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 g/mL and 391 controls (MIC < 2 g/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated vancomycin MIC. Elevated vancomycin MIC was associated with baseline hemodialysis, prior MRSA colonization, and metastatic infection.

Original language	English
Article number	e87
Journal	Antimicrobial Stewardship and Healthcare Epidemiology
Volume	3
Issue number	1
DOIs	https://doi.org/10.1017/ash.2023.163
State	Published - 1 May 2023

Access to Document

10.1017/ash.2023.163

Cite this

Mills, A. G., Dupper, A. C., Chacko, K. I., Alburquerque, B., Nadkarni, D., Berbel Caban, A., Fox, L., Gitman, M. R., Obla, A., Van Bakel, H., & Altman, D. R. (2023). Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations. Antimicrobial Stewardship and Healthcare Epidemiology, 3(1), Article e87. https://doi.org/10.1017/ash.2023.163

@article{8542d7648ce04d95918c2c832e5384ef,

title = "Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations",

abstract = "This case-control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 g/mL and 391 controls (MIC < 2 g/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated vancomycin MIC. Elevated vancomycin MIC was associated with baseline hemodialysis, prior MRSA colonization, and metastatic infection.",

author = "Mills, \{Alexandra G.\} and Dupper, \{Amy C.\} and Chacko, \{Kieran I.\} and Bremy Alburquerque and Devika Nadkarni and \{Berbel Caban\}, Ana and Lindsey Fox and Gitman, \{Melissa R.\} and Ajay Obla and \{Van Bakel\}, Harm and Altman, \{Deena R.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.",

year = "2023",

month = may,

day = "1",

doi = "10.1017/ash.2023.163",

language = "English",

volume = "3",

journal = "Antimicrobial Stewardship and Healthcare Epidemiology",

issn = "2732-494X",

publisher = "Cambridge University Press",

number = "1",

}

Mills, AG, Dupper, AC, Chacko, KI, Alburquerque, B, Nadkarni, D, Berbel Caban, A, Fox, L, Gitman, MR, Obla, A, Van Bakel, H & Altman, DR 2023, 'Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations', Antimicrobial Stewardship and Healthcare Epidemiology, vol. 3, no. 1, e87. https://doi.org/10.1017/ash.2023.163

TY - JOUR

T1 - Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

AU - Mills, Alexandra G.

AU - Dupper, Amy C.

AU - Chacko, Kieran I.

AU - Alburquerque, Bremy

AU - Nadkarni, Devika

AU - Berbel Caban, Ana

AU - Fox, Lindsey

AU - Gitman, Melissa R.

AU - Obla, Ajay

AU - Van Bakel, Harm

AU - Altman, Deena R.

PY - 2023/5/1

Y1 - 2023/5/1

N2 - This case-control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 g/mL and 391 controls (MIC < 2 g/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated vancomycin MIC. Elevated vancomycin MIC was associated with baseline hemodialysis, prior MRSA colonization, and metastatic infection.

AB - This case-control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 g/mL and 391 controls (MIC < 2 g/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated vancomycin MIC. Elevated vancomycin MIC was associated with baseline hemodialysis, prior MRSA colonization, and metastatic infection.

UR - https://www.scopus.com/pages/publications/85159326048

U2 - 10.1017/ash.2023.163

DO - 10.1017/ash.2023.163

M3 - Article

AN - SCOPUS:85159326048

SN - 2732-494X

VL - 3

JO - Antimicrobial Stewardship and Healthcare Epidemiology

JF - Antimicrobial Stewardship and Healthcare Epidemiology

IS - 1

M1 - e87

ER -

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

Abstract

Access to Document

Fingerprint

Cite this